Fractional Ablative Device Clears and Smoothes Skin

The Pixel Omnifit fractionated CO2 handpiece uses an existing CO2 laser to combine the effectiveness of an ablative approach with a patient comfort level and convenience that approaches a non-ablative solution. The system works with almost any existing CO2 resurfacing laser. The Pixel CO2 Omnifit clears photo-damaged skin; smoothes fine lines, wrinkles, and rhytids; shrinks the appearance of pores; fills in acne scars; and blends uneven pigmentation. One of the most important features of the handpiece is that it reduces ablative patient downtime from about 30 days to approximately three, making the procedure as appealing as many non-invasive approaches available today. The Pixel Omnifit fractionated CO2 handpiece is a product of Alma Lasers (Caesarea, Israel), and has been approved by the U.S. Food and Drug Administration (FDA).

"We are extremely pleased to announce the FDA's clearance of the Pixel CO2 Omnifit handpiece for skin resurfacing as it offers patients an effective treatment with minimal downtime compared to existing treatments,” said Howard Kelly, CEO of Alma Lasers. "This latest regulatory milestone allows us to continue to build on the success we have had with meeting physicians' needs for innovative and patient-focused solutions in the current aesthetic treatment marketplace.”

"I have had outstanding results treating my patients with fractionated CO2 skin resurfacing,” said Benjamin Raab, M.D., an assistant professor of clinical dermatology at Northwestern University Medical School (Chicago, IL, USA). "This will soon become the treatment of choice for patients seeking significant cosmetic improvements for aging and photo-damage without complications or prolonged healing time.”

Related Links:
Alma Lasers